Sanofi- and Gilead Sciences-backed Nurix Therapeutics is following suit with rival biotech Kymera in raising a major cash haul for its protein modulation R&D...

Dear colleagues and fellow "drug discoverers", we are happy to invite you to the first ISR-Openscreen workshop and conference, which will take place at the W...

On Wednesday, the FDA approved Medtronic’s hybrid closed-loop system, the world’s first “artificial pancreas.” The agency nod comes months ahead of the sprin...

Synthetic biology is driving a new era of medicine through the genetic programming of living cells. One particular area of focus has been the engineering of ...

Global CAR T Cell Therapy Market Innovation By Leading Players Novartis International AG, Kite Pharma, Inc. (Gilead Sciences, Inc.), Juno Therapeutics (Celge...

Quell Therapeutics, a London-based biotech developing immune cell therapies to target transplant rejection and autoimmune and inflammatory diseases.